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Abstract 
The current study evaluates a rapid Real-Time Polymerase Chain reaction (RT-PCR) based assay for the detection of 
Mycobacterium tuberculosis complex (MTC) strains by targeting the IS6110 insertion element. In addition,  hydrolysis 
probes were used, in this investigation for the diagnosis of Drug Resistance to genotype specific point mutations in rpo B 
and kat G genes in Mycobacterium tuberculosis that confer  resistance to rifampin (RIF) and isoniazid (INH) respectively,. 
This assay demonstrated high degree of sensitivity for detection Mycobacterium Tuberculosis. This method provides a 
rapid, sensitive and robust protocol for diagnosis of Multi Drug Resistant (MDR) MTB and offers several advantages 
over current molecular and culture-based techniques. 
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Introduction 
TB is one of the leading causes of mortality in 
India, killing two persons every three minutes, thus 
nearly 1,000 per day (Directorate of Health Services, 
India, 2009). An estimated 2 billion people worldwide 
are infected with Mycobacterium tuberculosis (MTB), 
which remains a vast reservoir of potential tuberculosis 
cases. T.B is the major co infection in HIV patients 
(Steinbrook, 2007). At present, about 5% of new 
tuberculosis cases in India occur in people infected 
with HIV infection. An extremely worrisome aspect of 
MTB is a recent rise in   Multi Drug Resistance (MDR) 
MTB cases in several countries. New MDR MTB cases 
according to WHO estimates, constitute about 5% i.e. 
half million of nine million all types of TB (WHO, 2009). 
In a study conducted on a cohort of patients from urban 
population near Mumbai recently, a very high (51%) 
incidence of MDR- MTB was reported (Almeida et al., 
2003) .MDR has now been recognized as a major 
public health problem that threatens success of DOTS, 
the WHO-recommended treatment approach for 
detection and cure of TB, as well as global tuberculosis 
control (WHO, 2009). 
Currently, the routine diagnosis of TB is based on 
microscopy (AFB- staining) and culture of MTB. The 
microscope based technique lacks sensitivity. The 
culture diagnosis though sensitive takes 2-3 weeks, 
with additional weeks for diagnosis of drug resistance. 
Such delayed diagnosis facilitates further transmission 
of T.B. If MDR remains undetected, the patient not only 
suffers from drug toxicity but also continues 
transmission of MDR bacilli. A quick and reliable 
diagnosis can permit early chemotherapeutic 
intervention and hence interrupt transmission. This 
could improve prognosis and avoid improper, 
ineffective medication as well as drug toxicity. Quicker 
diagnosis and appropriate therapies should therefore 
be accorded top priorities in controlling this growing 
epidemic. 
Molecular diagnostic methods such as 
conventional PCR, though faster than culture diagnosis, 
have variable success in diagnostic mycobacteriology 
(Brisson et al., 1991). RT-PCR, the new innovation of 
PCR, which is faster, more sensitive, has now been 
accredited for diagnosis of H1N1. Its features such as 
High Resolution Melt analysis (HRM) have diverse, 
powerful applications. HRM of the amplified sequences 
can be used to identify mutations in the targeted region. 
RT-PCR involving fluorogenic probes, has been 
successfully used for rapid detection and identification 
of a variety of microorganisms, including MTB and their 
mutants (Yoshinob et al., 2000, Bruijnesteijn van 
cooperate et al., 2004 and Johansen et al., 2004). 
Such detection of drug resistant MTB, carried out in 
some European (Spanish, Polish and Romanian) 
populations, (Toress et al., 2000 , Marín et al., 2004, 
Sajduda  et al., 2004 and Hristea et al., 2010) show 
immense promise. No such study has so far been 
reported in Indian population that harbors 20% MTB 
patients, and a significant proportion of MDR-MTB 
patients of world. Validation and application of such 
assay for routine diagnosis could thus have a very 
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significant impact on the control of transmission of TB. 
In these studies we have evaluated a very rapid RT-
PCR based assay for diagnosis of MTB, targeting 
IS6110, present in the MTB genome in multiple copies 
(Thierry et al., 1991a, b). 
Drug resistance in MTB has been characterized 
by a number of mutations in genes that are involved in 
drug targets/ metabolism. Mutations in rpo B and kat G 
genes of MTB have been shown to be responsible for 
resistance to rifampin (RIF) and isoniazid (INH) - 
respectively (WHO, 2008). Ninety-five percent of 
mutations for RIF resistance are located in 81-bp 
region of the rpo B gene that codes for the β subunit of 
RNA polymerase. Mutations in codon 315 of the kat G 
(Viedma et al., 2002) seem to be associated with 
higher levels of resistance to INH in 60-70 % of cases.  
In present studies, hydrolysis probe based protocols 
are used to amplify mutation containing regions of rpo 
B and kat G, and characterize mutations with the help 
of Melting curve analysis (Toress et al., 2000).  
 
Materials and Methods 
Study Group 
Sputum samples were obtained from 43 (n = 43) 
patients (with appropriate consent) from MGM Hospital, 
Navi Mumbai and Jayalaxmi Clinic, Govandi, Mumbai. 
In 40 of these cases independent Microscopy and 
Culture diagnosis of sputum samples was available. In 
the other 3 naïve, untreated cases, culture diagnosis 
was not available.   
 
Extraction of Mycobacterium DNA  
Sputum samples were decontaminated by Petroff 
method (Groothuis et al., 1991). DNA extracted by 
QIAamp nucleic acid mini kit (Qiagen, The Netherlands) 
was used for PCR as per manufacturer’s instructions. 
 
Real Time PCR 
For diagnosis of MTB infection, RT-PCR based 
amplification was performed on Syber Green Detection 
format (Roche Light Cycler 480, Mannheim, Germany) 
using primers (ISF / ISR). The assay detects a 123-bp 
region from the M. tuberculosis complex-specific 
insertion sequence IS6110. RT-PCR of MTB with 
Syber Green detection involved  following steps: 
Incubation at 95°C for 10 min; followed by 45 cycles, 
each one with :95°C for 10 s, 60°C for 20 s and 72°C 
for 10 s;. Since Syber Green intercalates with double 
stranded PCR products (Morrison et al., 1998), melting 
curve analysis was performed following amplification, 
to characterize amplimers by their respective melting 
temperatures. Melt analysis included preincubation of 
amplimers at 95°C for 1min, 40°C for 1 min, followed 
by heating up to 95°C at a rate of 0.1°C/s with 
concomitant monitoring the decrease in fluorescence. 
Rate of decrease of fluorescence intensity (-dF/dT) 
was plotted to obtain Tm value for each Melt curve. 
The total time for RT-PCR and subsequent Melting 
curve analysis was < 90 mins. 
Separate Melt Curve Analysis were performed by 
adapting a previously described protocol and primer-
probes (Torres et al, 2000) designed for detection RIF 
and INH resistance mutations. The hydrolysis probes 
used in this study , spanned 81 bp region of rpo B and 
the 315 codon region of kat G  that contain  mutations 
associated with resistance to RIF and INH respectively. 
All primers and probes were synthesized by TIB 
Molbiol (DNA Synthesis Service; Roche Diagnostics, 
Berlin, Germany). The RT-PCR was followed by 
melting curve analysis was also performed on the Light 
Cycler 480. This takes total time up to 90min 
appropriate controls were included in each 
experimental run.  
 
Results and Discussion 
Diagnosis of MTB: PCR based amplification using 
primers specific to IS6110 and SYBR Green I detection 
format was indicative of positive diagnosis of MTB 
(Fig.1a, 1b) for all the 43 cases studied. The Cp values 
(inversely proportional to the initial concentration of 
MTB-DNA) ranged between 20-35 cycles, indicating 
wide range of concentrations of MTB in the respective 
sputum samples. Gradual heating of amplified products 
from 40-95°C following amplification, generated  Melt 
curves, yielding Tm values, that depend on length and 
sequence of respective amplimers. These values 
provide (88.80C ± 0.5) characterization of amplimers 
and confirmation of positive diagnosis of MTB. 
Amplification profile- Melt analysis based diagnosis 
was found to be in complete agreement with culture 
diagnosis available for 40 culture positive cases 
studied. No false positives or false negatives were 
observed in this cohort of cases. It was of interest that 
such high sensitivity was observed with syber-green 
platform, which does not require expensive 
fluorescently labeled probes. These quick procedures 
involves only about 1.5 hrs of RT-PCR and melt 
analysis. Prior decontamination (2-3 hrs) and extraction 
of DNA (0.25 hrs) together require less than about 3 
hrs. In comparison, routine culture diagnosis of MTB 
takes 2-3 weeks, Bactec method requires about 8-10 
days. It is claimed (John et al., 2010) that Hybridization 
based diagnosis developed recently, requires up to 3-4 
days (Boehme et al., 2010). In the present study RT-
PCR based detection using IS6110 specific primer 
pairs displayed sensitivity ~100%.  Thus this RT-PCR 
based assay seems to offer a highly sensitive and 
rapid method for diagnosis of MTB. 
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Fig. 1a: Accumulation of Green Fluorescence during RT-
PCR using ISf-ISR6 primer pair with MTB-DNA extracted from 
sputum samples from different patients. Fig. 1b: Derivative 
melting curve of -dF/dT versus Melting Temperature using 
SYBR Green detection format for MTB DNA extracted from 
sputum of a patient 






Diagnosis of MDR-MTB: For MDR diagnosis, specific 
sequences spanning mutation hot spots were amplified 
by respective primers and screened by fluorescently 
labeled hydrolysis probes. The amplification profiles for 
rpo B or kat G sequences have little implication for 
diagnosis, as these are not specific to MTB complex. 
Therefore only probe-amplimer melt profiles of rpo B 
and kat G have been included in the figures (Fig.  2a, 
2b). Tm values obtained for these profiles are 
compared with corresponding data from Torres et al 
(Table-1a). In all, 16 cases displayed RIF resistance 
genotype, of which 4 indicated mutations at codon 526 
and 12 at codon 531. 11 cases displayed susceptible 
genotype, with absence of any mutation. Similar 
comparison for INH resistance indicated presence of 7 
cases each for AGC>AAC and AGC>ACC mutations in 
codon 315. No such mutations could be detected in 10 
cases. This diagnosis of drug response for various 
categories based on RT-PCR-HRM was compared with 
corresponding culture diagnosis (Table-1b). These 
cases fall into of 3 categories: Resistance to RIF and 
INH, Sensitive to both drugs and sensitive to one of the 
drugs. There was complete agreement between 
diagnoses from RT-PCR and Culture in 38 cases out of 
40 cases. Discordance was observed in only 2 RIF-
R/INH-S cases (Table-1a). While these cases were 
diagnosed as sensitive to both drugs by culture, they 
were found be resistant to RIF alone by RT-PCR assay.  
Assuming that the culture diagnosis was correct, this 
indicates 2 false positives for RIF resistance. No false 
negative case for RIF was observed. Interestingly no 
false positive or false negative cases were observed 
for resistance to INH in this study. Thus although the 
study is conducted on limited no of patients, yet it 
brings out high sensitivity of the RT-PCR based assay 
for detection of drug resistance.  
 
Fig. 2a: Derivative melting curves dF/dT of Red 640-labeled rpo 
sensor probe with samples containing mutations in codons. . 
Each trace shows the change in fluorescence ratio with time with 
respect to temperature, thus allowing calculation of the 
temperature at which the probe detaches from the PCR product. 
Susceptible refers to MTB that doesn’t contain drug resistance 
point mutation. Fig. 2b: Derivative melting curves (dF/dT) of Red 
640-labeled kat sensor probe with samples containing mutations 
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Table 1a: Tms values and corresponding Genotypes for RIF and INH mutations 
 










MTB Resistance to RIF is associated with 8 
different point mutations clustered in 81bp region of rpo 
B gene (Toress et al). Of these only 2 can be detected 
efficiently with the probes used in this study. It is 
possible that better probes, with more resolving power 
can improve specificity of this assay. In contrast, 2 
mutations in kat G account for most of the cases of 
INH- resistance (Table-1a).The study indicates that 
both of these can be screened efficiently with the probe 
used in Indian context. The sensitivity and specificity of 
Probe based assays seem to depend on the design of 
the probes used. Thus it would be of interest to 
compare sensitivity of different combinations of primer-
probes for detection of specific mutations in Indian 
population. In particular, sets of primers and probes 
that permit multiplex RT-PCR for detection of both MTB 
as well as MDR MTB would be desirable, as these 
would obviate need for separate PCR for MTB and 
MDR.  
Very interestingly, in 3 naïve cases suspected of 
TB, the RT-PCR diagnosis was confirmed by RT-PCR 
that they were resistant to both RIF and INH. Culture 
diagnosis is not available for these cases so far. The 
present study is not designed to monitor incidence of 
various RIF and INH mutations in Indian population. 
However it does underline the usefulness of protocols 
to screen both naïve as well as treated cases. This is 
particularly important if the incidence of MDR is as high 
as 51% in urban Indian population as reported 
(Almeida et al, 2003). With diagnosis by a rapid assay, 
such as described here, appropriate treatment could be 
initiated promptly, in such naïve cases, to interrupt 
transmission to improve prognosis, and avoid 
unwarranted drug toxicity. 
The study carried out for the first time in Indian 
context, brings out high sensitivity of RT-PCR based 
detection of MTB and resistance to RIF and INH.  
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